{
    "abstract": "Although RTS,S remains the most advanced malaria vaccine, the factors influencing differences in vaccine immunogenicity or efficacy between individuals or populations are still poorly characterised. The analyses of genetic determinants of immunogenicity have previously been restricted by relatively small sample sizes from individual trials. Here we combine data from six Phase II RTS,S trials and evaluate the relationship between HLA allele groups and RTS,S-mediated protection in controlled human malaria infections (CHMI), using multivariate logistic or linear regression. We observed significant associations between three allele groups (HLA-A\u221701, HLA-B\u221708, and HLA-DRB1\u221715/\u221716) and protection, while another three allele groups (HLA-A\u221703, HLA-B\u221753, and HLA-DRB1\u221707) were significantly associated with lack of protection. It is noteworthy that these \u2018protective\u2019 allele groups are thought to be at a lower prevalence in sub-Saharan African populations than in the UK or USA where these Phase II trials occurred. Taken together, the analyses presented here give an indication that HLA genotype may influence RTS,S-mediated protective efficacy against malaria infection.",
    "bib_entries": {
        "b0005": null,
        "b0010": {
            "authors": [],
            "doi": "10.1016/S0140-6736(15)60721-8",
            "firstpage": "31",
            "issn": "01406736",
            "lastpage": "45",
            "pmid": "25913272",
            "pub_year": 2015,
            "title": "Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: Final results of a phase 3, individually randomised, controlled trial",
            "volume": "386"
        },
        "b0015": null,
        "b0020": {
            "authors": [
                {
                    "first": "Jason A.",
                    "initial": "J.A.",
                    "last": "Regules"
                },
                {
                    "first": "Susan B.",
                    "initial": "S.B.",
                    "last": "Cicatelli"
                },
                {
                    "first": "Jason W.",
                    "initial": "J.W.",
                    "last": "Bennett"
                },
                {
                    "first": "Kristopher M.",
                    "initial": "K.M.",
                    "last": "Paolino"
                },
                {
                    "first": "Patrick S.",
                    "initial": "P.S.",
                    "last": "Twomey"
                },
                {
                    "first": "James E.",
                    "initial": "J.E.",
                    "last": "Moon"
                },
                {
                    "first": "April K.",
                    "initial": "A.K.",
                    "last": "Kathcart"
                },
                {
                    "first": "Kevin D.",
                    "initial": "K.D.",
                    "last": "Hauns"
                },
                {
                    "first": "Jack L.",
                    "initial": "J.L.",
                    "last": "Komisar"
                },
                {
                    "first": "Aziz N.",
                    "initial": "A.N.",
                    "last": "Qabar"
                },
                {
                    "first": "Silas A.",
                    "initial": "S.A.",
                    "last": "Davidson"
                },
                {
                    "first": "Sheetij",
                    "initial": "S.",
                    "last": "Dutta"
                },
                {
                    "first": "Matthew E.",
                    "initial": "M.E.",
                    "last": "Griffith"
                },
                {
                    "first": "Charles D.",
                    "initial": "C.D.",
                    "last": "Magee"
                },
                {
                    "first": "Mariusz",
                    "initial": "M.",
                    "last": "Wojnarski"
                },
                {
                    "first": "Jeffrey R.",
                    "initial": "J.R.",
                    "last": "Livezey"
                },
                {
                    "first": "Adrian T.",
                    "initial": "A.T.",
                    "last": "Kress"
                },
                {
                    "first": "Paige E.",
                    "initial": "P.E.",
                    "last": "Waterman"
                },
                {
                    "first": "Erik",
                    "initial": "E.",
                    "last": "Jongert"
                },
                {
                    "first": "Ulrike",
                    "initial": "U.",
                    "last": "Wille-Reece"
                },
                {
                    "first": "Wayne",
                    "initial": "W.",
                    "last": "Volkmuth"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Emerling"
                },
                {
                    "first": "William H.",
                    "initial": "W.H.",
                    "last": "Robinson"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Lievens"
                },
                {
                    "first": "Danielle",
                    "initial": "D.",
                    "last": "Morelle"
                },
                {
                    "first": "Cynthia K.",
                    "initial": "C.K.",
                    "last": "Lee"
                },
                {
                    "first": "Bebi",
                    "initial": "B.",
                    "last": "Yassin-Rajkumar"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Weltzin"
                },
                {
                    "first": "Joe",
                    "initial": "J.",
                    "last": "Cohen"
                },
                {
                    "first": "Robert M.",
                    "initial": "R.M.",
                    "last": "Paris"
                },
                {
                    "first": "Norman C.",
                    "initial": "N.C.",
                    "last": "Waters"
                },
                {
                    "first": "Ashley J.",
                    "initial": "A.J.",
                    "last": "Birkett"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Kaslow"
                },
                {
                    "first": "W. Ripley",
                    "initial": "W.R.",
                    "last": "Ballou"
                },
                {
                    "first": "Christian F.",
                    "initial": "C.F.",
                    "last": "Ockenhouse"
                },
                {
                    "first": "Johan",
                    "initial": "J.",
                    "last": "Vekemans"
                }
            ],
            "doi": "10.1093/infdis/jiw237",
            "firstpage": "762",
            "issn": "00221899",
            "lastpage": "771",
            "pmid": "27296848",
            "pub_year": 2016,
            "title": "Fractional third and fourth dose of RTS,S/AS01 malaria candidate vaccine: A phase 2a controlled human malaria parasite infection and immunogenicity study",
            "volume": "214"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Brunella",
                    "initial": "B.",
                    "last": "Posteraro"
                },
                {
                    "first": "Roberta",
                    "initial": "R.",
                    "last": "Pastorino"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Di Giannantonio"
                },
                {
                    "first": "Carolina",
                    "initial": "C.",
                    "last": "Ianuale"
                },
                {
                    "first": "Rosarita",
                    "initial": "R.",
                    "last": "Amore"
                },
                {
                    "first": "Walter",
                    "initial": "W.",
                    "last": "Ricciardi"
                },
                {
                    "first": "Stefania",
                    "initial": "S.",
                    "last": "Boccia"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.01.057",
            "firstpage": "1661",
            "issn": "0264410X",
            "lastpage": "1669",
            "pmid": "24513009",
            "pub_year": 2014,
            "title": "The link between genetic variation and variability in vaccine responses: Systematic review and meta-analyses",
            "volume": "32"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Zheng Kang",
                    "initial": "Z.K.",
                    "last": "Li"
                },
                {
                    "first": "Jing Jing",
                    "initial": "J.J.",
                    "last": "Nie"
                },
                {
                    "first": "Jie",
                    "initial": "J.",
                    "last": "Li"
                },
                {
                    "first": "Hui",
                    "initial": "H.",
                    "last": "Zhuang"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.06.108",
            "firstpage": "4355",
            "issn": "0264410X",
            "lastpage": "4361",
            "pmid": "23887040",
            "pub_year": 2013,
            "title": "The effect of HLA on immunological response to hepatitis B vaccine in healthy people: A meta-analysis",
            "volume": "31"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Inna G.",
                    "initial": "I.G.",
                    "last": "Ovsyannikova"
                },
                {
                    "first": "V. Shane",
                    "initial": "V.S.",
                    "last": "Pankratz"
                },
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Vierkant"
                },
                {
                    "first": "Nicholas M.",
                    "initial": "N.M.",
                    "last": "Pajewski"
                },
                {
                    "first": "Conrad P.",
                    "initial": "C.P.",
                    "last": "Quinn"
                },
                {
                    "first": "Richard A.",
                    "initial": "R.A.",
                    "last": "Kaslow"
                },
                {
                    "first": "Robert M.",
                    "initial": "R.M.",
                    "last": "Jacobson"
                },
                {
                    "first": "Gregory A.",
                    "initial": "G.A.",
                    "last": "Poland"
                }
            ],
            "doi": "10.1128/IAI.00269-13",
            "firstpage": "2584",
            "issn": "00199567",
            "lastpage": "2591",
            "pmid": "23649091",
            "pub_year": 2013,
            "title": "Human leukocyte antigens and cellular immune responses to anthrax vaccine adsorbed",
            "volume": "81"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Alastair J.",
                    "initial": "A.J.",
                    "last": "Moss"
                },
                {
                    "first": "Fiona P.",
                    "initial": "F.P.",
                    "last": "Gaughran"
                },
                {
                    "first": "Aliyye",
                    "initial": "A.",
                    "last": "Karasu"
                },
                {
                    "first": "Anthony S.",
                    "initial": "A.S.",
                    "last": "Gilbert"
                },
                {
                    "first": "Alex J.",
                    "initial": "A.J.",
                    "last": "Mann"
                },
                {
                    "first": "Colin M.",
                    "initial": "C.M.",
                    "last": "Gelder"
                },
                {
                    "first": "John S.",
                    "initial": "J.S.",
                    "last": "Oxford"
                },
                {
                    "first": "Henry A.",
                    "initial": "H.A.",
                    "last": "Stephens"
                },
                {
                    "first": "Rob",
                    "initial": "R.",
                    "last": "Lambkin-Williams"
                }
            ],
            "doi": "10.1371/journal.pone.0071376",
            "issn": "19326203",
            "pub_year": 2013,
            "title": "Correlation between Human Leukocyte Antigen Class II Alleles and HAI Titers Detected Post-Influenza Vaccination",
            "volume": "8"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Tzu Wei",
                    "initial": "T.W.",
                    "last": "Wu"
                },
                {
                    "first": "Chen Chung",
                    "initial": "C.C.",
                    "last": "Chu"
                },
                {
                    "first": "Tzu Ying",
                    "initial": "T.Y.",
                    "last": "Ho"
                },
                {
                    "first": "Huei Wen",
                    "initial": "H.W.",
                    "last": "Chang Liao"
                },
                {
                    "first": "Sheng Kai",
                    "initial": "S.K.",
                    "last": "Lin"
                },
                {
                    "first": "Marie",
                    "initial": "M.",
                    "last": "Lin"
                },
                {
                    "first": "Hans Hsienhong",
                    "initial": "H.H.",
                    "last": "Lin"
                },
                {
                    "first": "Li Yu",
                    "initial": "L.Y.",
                    "last": "Wang"
                }
            ],
            "doi": "10.1007/s00439-013-1320-5",
            "firstpage": "1131",
            "issn": "03406717",
            "lastpage": "1139",
            "pmid": "23739870",
            "pub_year": 2013,
            "title": "Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents",
            "volume": "132"
        },
        "b0050": {
            "authors": [
                {
                    "first": "T. W.",
                    "initial": "T.W.",
                    "last": "Wu"
                },
                {
                    "first": "C. C.",
                    "initial": "C.C.",
                    "last": "Chu"
                },
                {
                    "first": "H. W.",
                    "initial": "H.W.",
                    "last": "Chang Liao"
                },
                {
                    "first": "S. K.",
                    "initial": "S.K.",
                    "last": "Lin"
                },
                {
                    "first": "T. Y.",
                    "initial": "T.Y.",
                    "last": "Ho"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Lin"
                },
                {
                    "first": "H. H.",
                    "initial": "H.H.",
                    "last": "Lin"
                },
                {
                    "first": "L. Y.",
                    "initial": "L.Y.",
                    "last": "Wang"
                }
            ],
            "doi": "10.1038/gene.2013.62",
            "firstpage": "47",
            "issn": "14664879",
            "lastpage": "53",
            "pmid": "24285177",
            "pub_year": 2014,
            "title": "HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy",
            "volume": "15"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Vasee S.",
                    "initial": "V.S.",
                    "last": "Moorthy"
                },
                {
                    "first": "W. Ripley",
                    "initial": "W.R.",
                    "last": "Ballou"
                }
            ],
            "doi": "10.1186/1475-2875-8-312",
            "issn": "14752875",
            "pmid": "20042088",
            "pub_year": 2009,
            "title": "Immunological mechanisms underlying protection mediated by RTS,S: A review of the available data",
            "volume": "8"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Schwenk"
                },
                {
                    "first": "Joanne M.",
                    "initial": "J.M.",
                    "last": "Lumsden"
                },
                {
                    "first": "Lisa E.",
                    "initial": "L.E.",
                    "last": "Rein"
                },
                {
                    "first": "Laure",
                    "initial": "L.",
                    "last": "Juompan"
                },
                {
                    "first": "Kent E.",
                    "initial": "K.E.",
                    "last": "Kester"
                },
                {
                    "first": "D. Gray",
                    "initial": "D.G.",
                    "last": "Heppner"
                },
                {
                    "first": "Urszula",
                    "initial": "U.",
                    "last": "Krzych"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.09.098",
            "firstpage": "8847",
            "issn": "0264410X",
            "lastpage": "8854",
            "pmid": "21983360",
            "pub_year": 2011,
            "title": "Immunization with the RTS,S/AS malaria vaccine induces IFN-\u03b3 +CD4 T cells that recognize only discrete regions of the circumsporozoite protein and these specificities are maintained following booster immunizations and challenge",
            "volume": "29"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Martha",
                    "initial": "M.",
                    "last": "Sedegah"
                },
                {
                    "first": "Yohan",
                    "initial": "Y.",
                    "last": "Kim"
                },
                {
                    "first": "Harini",
                    "initial": "H.",
                    "last": "Ganeshan"
                },
                {
                    "first": "Jun",
                    "initial": "J.",
                    "last": "Huang"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Belmonte"
                },
                {
                    "first": "Esteban",
                    "initial": "E.",
                    "last": "Abot"
                },
                {
                    "first": "Jo Glenna",
                    "initial": "J.G.",
                    "last": "Banania"
                },
                {
                    "first": "Fouzia",
                    "initial": "F.",
                    "last": "Farooq"
                },
                {
                    "first": "Shannon",
                    "initial": "S.",
                    "last": "McGrath"
                },
                {
                    "first": "Bjoern",
                    "initial": "B.",
                    "last": "Peters"
                },
                {
                    "first": "Alessandro",
                    "initial": "A.",
                    "last": "Sette"
                },
                {
                    "first": "Lorraine",
                    "initial": "L.",
                    "last": "Soisson"
                },
                {
                    "first": "Carter",
                    "initial": "C.",
                    "last": "Diggs"
                },
                {
                    "first": "Denise L.",
                    "initial": "D.L.",
                    "last": "Doolan"
                },
                {
                    "first": "Cindy",
                    "initial": "C.",
                    "last": "Tamminga"
                },
                {
                    "first": "Eileen",
                    "initial": "E.",
                    "last": "Villasante"
                },
                {
                    "first": "Michael R.",
                    "initial": "M.R.",
                    "last": "Hollingdale"
                },
                {
                    "first": "Thomas L.",
                    "initial": "T.L.",
                    "last": "Richie"
                }
            ],
            "doi": "10.1186/1475-2875-12-185",
            "issn": "14752875",
            "pmid": "23738590",
            "pub_year": 2013,
            "title": "Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)",
            "volume": "12"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Silayuv E.",
                    "initial": "S.E.",
                    "last": "Bongfen"
                },
                {
                    "first": "Ralph",
                    "initial": "R.",
                    "last": "Torgler"
                },
                {
                    "first": "Jackeline F.",
                    "initial": "J.F.",
                    "last": "Romero"
                },
                {
                    "first": "Laurent",
                    "initial": "L.",
                    "last": "Renia"
                },
                {
                    "first": "Giampietro",
                    "initial": "G.",
                    "last": "Corradin"
                }
            ],
            "doi": "10.4049/jimmunol.178.11.7054",
            "firstpage": "7054",
            "issn": "00221767",
            "lastpage": "7063",
            "pmid": "17513754",
            "pub_year": 2007,
            "title": "Plasmodium berghei-infected primary hepatocytes process and present the circumsporozoite protein to specific CD8+ T cells in vitro",
            "volume": "178"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Kent E.",
                    "initial": "K.E.",
                    "last": "Kester"
                },
                {
                    "first": "Denise A.",
                    "initial": "D.A.",
                    "last": "McKinney"
                },
                {
                    "first": "Nadia",
                    "initial": "N.",
                    "last": "Tornieporth"
                },
                {
                    "first": "Christian F.",
                    "initial": "C.F.",
                    "last": "Ockenhouse"
                },
                {
                    "first": "D. Gray",
                    "initial": "D.G.",
                    "last": "Heppner"
                },
                {
                    "first": "Ted",
                    "initial": "T.",
                    "last": "Hall"
                },
                {
                    "first": "Bruce T.",
                    "initial": "B.T.",
                    "last": "Wellde"
                },
                {
                    "first": "Kate",
                    "initial": "K.",
                    "last": "White"
                },
                {
                    "first": "Peifang",
                    "initial": "P.",
                    "last": "Sun"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Schwenk"
                },
                {
                    "first": "Urszula",
                    "initial": "U.",
                    "last": "Krzych"
                },
                {
                    "first": "Martine",
                    "initial": "M.",
                    "last": "Delchambre"
                },
                {
                    "first": "Gerald",
                    "initial": "G.",
                    "last": "Voss"
                },
                {
                    "first": "Marie Claude",
                    "initial": "M.C.",
                    "last": "Dubois"
                },
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Gasser"
                },
                {
                    "first": "Megan G.",
                    "initial": "M.G.",
                    "last": "Dowler"
                },
                {
                    "first": "Megan",
                    "initial": "M.",
                    "last": "O'Brien"
                },
                {
                    "first": "Janet",
                    "initial": "J.",
                    "last": "Wittes"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Wirtz"
                },
                {
                    "first": "Joe",
                    "initial": "J.",
                    "last": "Cohen"
                },
                {
                    "first": "W. Ripley",
                    "initial": "W.R.",
                    "last": "Ballou"
                }
            ],
            "doi": "10.1016/j.vaccine.2007.05.005",
            "firstpage": "5359",
            "issn": "0264410X",
            "lastpage": "5366",
            "pmid": "17574311",
            "pub_year": 2007,
            "title": "A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-na\u00efve adults",
            "volume": "25"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Kent E.",
                    "initial": "K.E.",
                    "last": "Kester"
                },
                {
                    "first": "James F.",
                    "initial": "J.F.",
                    "last": "Cummings"
                },
                {
                    "first": "Christian F.",
                    "initial": "C.F.",
                    "last": "Ockenhouse"
                },
                {
                    "first": "Robin",
                    "initial": "R.",
                    "last": "Nielsen"
                },
                {
                    "first": "B. Ted",
                    "initial": "B.T.",
                    "last": "Hall"
                },
                {
                    "first": "Daniel M.",
                    "initial": "D.M.",
                    "last": "Gordon"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "Schwenk"
                },
                {
                    "first": "Urszula",
                    "initial": "U.",
                    "last": "Krzych"
                },
                {
                    "first": "Carolyn A.",
                    "initial": "C.A.",
                    "last": "Holland"
                },
                {
                    "first": "Gregory",
                    "initial": "G.",
                    "last": "Richmond"
                },
                {
                    "first": "Megan G.",
                    "initial": "M.G.",
                    "last": "Dowler"
                },
                {
                    "first": "Jackie",
                    "initial": "J.",
                    "last": "Williams"
                },
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Wirtz"
                },
                {
                    "first": "Nadia",
                    "initial": "N.",
                    "last": "Tornieporth"
                },
                {
                    "first": "Laurence",
                    "initial": "L.",
                    "last": "Vigneron"
                },
                {
                    "first": "Martine",
                    "initial": "M.",
                    "last": "Delchambre"
                },
                {
                    "first": "Marie Ange",
                    "initial": "M.A.",
                    "last": "Demoitie"
                },
                {
                    "first": "W. Ripley",
                    "initial": "W.R.",
                    "last": "Ballou"
                },
                {
                    "first": "Joe",
                    "initial": "J.",
                    "last": "Cohen"
                },
                {
                    "first": "D. Gray",
                    "initial": "D.G.",
                    "last": "Heppner"
                }
            ],
            "doi": "10.1016/j.vaccine.2008.02.048",
            "firstpage": "2191",
            "issn": "0264410X",
            "lastpage": "2202",
            "pmid": "18387719",
            "pub_year": 2008,
            "title": "Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-na\u00efve adults at the Walter Reed Army Institute of Research",
            "volume": "26"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Kent E.",
                    "initial": "K.E.",
                    "last": "Kester"
                },
                {
                    "first": "James F.",
                    "initial": "J.F.",
                    "last": "Cummings"
                },
                {
                    "first": "Opokua",
                    "initial": "O.",
                    "last": "Ofori-Anyinam"
                },
                {
                    "first": "Christian F.",
                    "initial": "C.F.",
                    "last": "Ockenhouse"
                },
                {
                    "first": "Urszula",
                    "initial": "U.",
                    "last": "Krzych"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Moris"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Schwenk"
                },
                {
                    "first": "Robin A.",
                    "initial": "R.A.",
                    "last": "Nielsen"
                },
                {
                    "first": "Zufan",
                    "initial": "Z.",
                    "last": "Debebe"
                },
                {
                    "first": "Evgeny",
                    "initial": "E.",
                    "last": "Pinelis"
                },
                {
                    "first": "Laure",
                    "initial": "L.",
                    "last": "Juompan"
                },
                {
                    "first": "Jack",
                    "initial": "J.",
                    "last": "Williams"
                },
                {
                    "first": "Megan",
                    "initial": "M.",
                    "last": "Dowler"
                },
                {
                    "first": "V. Ann",
                    "initial": "V.A.",
                    "last": "Stewart"
                },
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Wirtz"
                },
                {
                    "first": "Marie Claude",
                    "initial": "M.C.",
                    "last": "Dubois"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Lievens"
                },
                {
                    "first": "Joe",
                    "initial": "J.",
                    "last": "Cohen"
                },
                {
                    "first": "W. Ripley",
                    "initial": "W.R.",
                    "last": "Ballou"
                },
                {
                    "first": "D. Gray",
                    "initial": "D.G.",
                    "last": "Heppner"
                }
            ],
            "doi": "10.1086/600120",
            "firstpage": "337",
            "issn": "00221899",
            "lastpage": "346",
            "pmid": "19569965",
            "pub_year": 2009,
            "title": "Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: Safety, efficacy, and immunologic associates of protection",
            "volume": "200"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Christian F.",
                    "initial": "C.F.",
                    "last": "Ockenhouse"
                },
                {
                    "first": "Jason",
                    "initial": "J.",
                    "last": "Regules"
                },
                {
                    "first": "Donna",
                    "initial": "D.",
                    "last": "Tosh"
                },
                {
                    "first": "Jessica",
                    "initial": "J.",
                    "last": "Cowden"
                },
                {
                    "first": "April",
                    "initial": "A.",
                    "last": "Kathcart"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Cummings"
                },
                {
                    "first": "Kristopher",
                    "initial": "K.",
                    "last": "Paolino"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Moon"
                },
                {
                    "first": "Jack",
                    "initial": "J.",
                    "last": "Komisar"
                },
                {
                    "first": "Edwin",
                    "initial": "E.",
                    "last": "Kamau"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Oliver"
                },
                {
                    "first": "Austin",
                    "initial": "A.",
                    "last": "Chhoeu"
                },
                {
                    "first": "Jitta",
                    "initial": "J.",
                    "last": "Murphy"
                },
                {
                    "first": "Kirsten",
                    "initial": "K.",
                    "last": "Lyke"
                },
                {
                    "first": "Matthew",
                    "initial": "M.",
                    "last": "Laurens"
                },
                {
                    "first": "Ashley",
                    "initial": "A.",
                    "last": "Birkett"
                },
                {
                    "first": "Cynthia",
                    "initial": "C.",
                    "last": "Lee"
                },
                {
                    "first": "Rich",
                    "initial": "R.",
                    "last": "Weltzin"
                },
                {
                    "first": "Ulrike",
                    "initial": "U.",
                    "last": "Wille-Reece"
                },
                {
                    "first": "Martha",
                    "initial": "M.",
                    "last": "Sedegah"
                },
                {
                    "first": "Jenny",
                    "initial": "J.",
                    "last": "Hendriks"
                },
                {
                    "first": "Isabella",
                    "initial": "I.",
                    "last": "Versteege"
                },
                {
                    "first": "Maria Grazia",
                    "initial": "M.G.",
                    "last": "Pau"
                },
                {
                    "first": "Jerold",
                    "initial": "J.",
                    "last": "Sadoff"
                },
                {
                    "first": "Yannick",
                    "initial": "Y.",
                    "last": "Vanloubbeeck"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Lievens"
                },
                {
                    "first": "Dirk",
                    "initial": "D.",
                    "last": "Heerwegh"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Moris"
                },
                {
                    "first": "Yolanda Guerra",
                    "initial": "Y.G.",
                    "last": "Mendoza"
                },
                {
                    "first": "Erik",
                    "initial": "E.",
                    "last": "Jongert"
                },
                {
                    "first": "Joe",
                    "initial": "J.",
                    "last": "Cohen"
                },
                {
                    "first": "Gerald",
                    "initial": "G.",
                    "last": "Voss"
                },
                {
                    "first": "W. Ripley",
                    "initial": "W.R.",
                    "last": "Ballou"
                },
                {
                    "first": "Johan",
                    "initial": "J.",
                    "last": "Vekemans"
                }
            ],
            "doi": "10.1371/journal.pone.0131571",
            "issn": "19326203",
            "pmid": "26148007",
            "pub_year": 2015,
            "title": "Ad35.CS.01 - RTS,S/AS01 heterologous prime boost vaccine efficacy against sporozoite challenge in healthy malaria-na\u00efve adults",
            "volume": "10"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Tommy",
                    "initial": "T.",
                    "last": "Rampling"
                },
                {
                    "first": "Katie J.",
                    "initial": "K.J.",
                    "last": "Ewer"
                },
                {
                    "first": "Georgina",
                    "initial": "G.",
                    "last": "Bowyer"
                },
                {
                    "first": "Carly M.",
                    "initial": "C.M.",
                    "last": "Bliss"
                },
                {
                    "first": "Nick J.",
                    "initial": "N.J.",
                    "last": "Edwards"
                },
                {
                    "first": "Danny",
                    "initial": "D.",
                    "last": "Wright"
                },
                {
                    "first": "Ruth O.",
                    "initial": "R.O.",
                    "last": "Payne"
                },
                {
                    "first": "Navin",
                    "initial": "N.",
                    "last": "Venkatraman"
                },
                {
                    "first": "Eoghan",
                    "initial": "E.",
                    "last": "De Barra"
                },
                {
                    "first": "Claudia M.",
                    "initial": "C.M.",
                    "last": "Snudden"
                },
                {
                    "first": "Ian D.",
                    "initial": "I.D.",
                    "last": "Poulton"
                },
                {
                    "first": "Hans",
                    "initial": "H.",
                    "last": "De Graaf"
                },
                {
                    "first": "Priya",
                    "initial": "P.",
                    "last": "Sukhtankar"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Roberts"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Ivinson"
                },
                {
                    "first": "Rich",
                    "initial": "R.",
                    "last": "Weltzin"
                },
                {
                    "first": "Bebi Yassin",
                    "initial": "B.Y.",
                    "last": "Rajkumar"
                },
                {
                    "first": "Ulrike",
                    "initial": "U.",
                    "last": "Wille-Reece"
                },
                {
                    "first": "Cynthia K.",
                    "initial": "C.K.",
                    "last": "Lee"
                },
                {
                    "first": "Christian F.",
                    "initial": "C.F.",
                    "last": "Ockenhouse"
                },
                {
                    "first": "Robert E.",
                    "initial": "R.E.",
                    "last": "Sinden"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Gerry"
                },
                {
                    "first": "Alison M.",
                    "initial": "A.M.",
                    "last": "Lawrie"
                },
                {
                    "first": "Johan",
                    "initial": "J.",
                    "last": "Vekemans"
                },
                {
                    "first": "Danielle",
                    "initial": "D.",
                    "last": "Morelle"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Lievens"
                },
                {
                    "first": "Ripley W.",
                    "initial": "R.W.",
                    "last": "Ballou"
                },
                {
                    "first": "Graham S.",
                    "initial": "G.S.",
                    "last": "Cooke"
                },
                {
                    "first": "Saul N.",
                    "initial": "S.N.",
                    "last": "Faust"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Gilbert"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                }
            ],
            "doi": "10.1093/infdis/jiw244",
            "firstpage": "772",
            "issn": "00221899",
            "lastpage": "781",
            "pmid": "27307573",
            "pub_year": 2016,
            "title": "Safety and high level efficacy of the combination malaria vaccine regimen of RTS,S/AS01B with chimpanzee adenovirus 63 and modified vaccinia Ankara vectored vaccines expressing me-trap",
            "volume": "214"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Matthew B.",
                    "initial": "M.B.",
                    "last": "Laurens"
                },
                {
                    "first": "Christopher J.",
                    "initial": "C.J.",
                    "last": "Duncan"
                },
                {
                    "first": "Judith E.",
                    "initial": "J.E.",
                    "last": "Epstein"
                },
                {
                    "first": "Adrian V.",
                    "initial": "A.V.",
                    "last": "Hill"
                },
                {
                    "first": "Jack L.",
                    "initial": "J.L.",
                    "last": "Komisar"
                },
                {
                    "first": "Kirsten E.",
                    "initial": "K.E.",
                    "last": "Lyke"
                },
                {
                    "first": "Christian F.",
                    "initial": "C.F.",
                    "last": "Ockenhouse"
                },
                {
                    "first": "Thomas L.",
                    "initial": "T.L.",
                    "last": "Richie"
                },
                {
                    "first": "Meta",
                    "initial": "M.",
                    "last": "Roestenberg"
                },
                {
                    "first": "Robert W.",
                    "initial": "R.W.",
                    "last": "Sauerwein"
                },
                {
                    "first": "Michele D.",
                    "initial": "M.D.",
                    "last": "Spring"
                },
                {
                    "first": "Angela K.",
                    "initial": "A.K.",
                    "last": "Talley"
                },
                {
                    "first": "Vasee S.",
                    "initial": "V.S.",
                    "last": "Moorthy"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.04.088",
            "firstpage": "5302",
            "issn": "0264410X",
            "lastpage": "5304",
            "pmid": "22659449",
            "pub_year": 2012,
            "title": "A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccines",
            "volume": "30"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Kenneth J.",
                    "initial": "K.J.",
                    "last": "Rothman"
                }
            ],
            "doi": "10.1097/00001648-199001000-00010",
            "firstpage": "43",
            "issn": "10443983",
            "lastpage": "46",
            "pmid": "2081237",
            "pub_year": 1990,
            "title": "No adjustments are needed for multiple comparisons",
            "volume": "1"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Price"
                },
                {
                    "first": "Campbell",
                    "initial": "C.",
                    "last": "Witt"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Allcock"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Sayer"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Garlepp"
                },
                {
                    "first": "Chee Choy",
                    "initial": "C.C.",
                    "last": "Kok"
                },
                {
                    "first": "Martyn",
                    "initial": "M.",
                    "last": "French"
                },
                {
                    "first": "Simon",
                    "initial": "S.",
                    "last": "Mallal"
                },
                {
                    "first": "Frank",
                    "initial": "F.",
                    "last": "Christiansen"
                }
            ],
            "doi": "10.1111/j.1600-065X.1999.tb01398.x",
            "firstpage": "257",
            "issn": "01052896",
            "lastpage": "274",
            "pmid": "10319267",
            "pub_year": 1999,
            "title": "The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases",
            "volume": "167"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Maiers"
                },
                {
                    "first": "Loren",
                    "initial": "L.",
                    "last": "Gragert"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Klitz"
                }
            ],
            "doi": "10.1016/j.humimm.2007.04.005",
            "firstpage": "779",
            "issn": "01988859",
            "lastpage": "788",
            "pmid": "17869653",
            "pub_year": 2007,
            "title": "High-resolution HLA alleles and haplotypes in the United States population",
            "volume": "68"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Catherine E.M.",
                    "initial": "C.E.M.",
                    "last": "Allsopp"
                },
                {
                    "first": "Dominic",
                    "initial": "D.",
                    "last": "Kwiatkowski"
                },
                {
                    "first": "Nicholas M.",
                    "initial": "N.M.",
                    "last": "Anstey"
                },
                {
                    "first": "Patrick",
                    "initial": "P.",
                    "last": "Twumasi"
                },
                {
                    "first": "Pamela A.",
                    "initial": "P.A.",
                    "last": "Rowe"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Bennett"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Brewster"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "McMichael"
                },
                {
                    "first": "Brian M.",
                    "initial": "B.M.",
                    "last": "Greenwood"
                }
            ],
            "doi": "10.1038/352595a0",
            "firstpage": "595",
            "issn": "00280836",
            "lastpage": "600",
            "pmid": "1865923",
            "pub_year": 1991,
            "title": "Common West African HLA antigens are associated with protection from severe malaria",
            "volume": "352"
        }
    },
    "body_text": [
        {
            "endOffset": 19467,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Of the 37 allele groups analysed, six had statistically significant associations with CHMI outcome as summarised in Table 2 and Fig. 1.",
            "startOffset": 19332,
            "title": "HLA allele groups are associated with protective efficacy of RTS,S vaccination"
        },
        {
            "endOffset": 27596,
            "parents": [],
            "secId": "s0080",
            "sentence": "A further allele group, HLA-DRB1\u221715/\u221716, was weakly associated with protection.",
            "startOffset": 27517,
            "title": "Discussion"
        },
        {
            "endOffset": 27911,
            "parents": [],
            "secId": "s0080",
            "sentence": "Neither excluding subjects who received viral vectored vaccines in addition to RTS,S, or adjusting for adjuvant and schedule (in addition to trial) substantially affected our conclusions.",
            "startOffset": 27724,
            "title": "Discussion"
        },
        {
            "endOffset": 31750,
            "parents": [],
            "secId": "s0080",
            "sentence": "However, this association was dependent on the host response to a liver stage antigen (not CS protein) and furthermore it is plausible that the allele group could have no role in preventing development of blood-stage malaria, as detected by blood smear in these Phase II trials, while having a role in the prevention of development of severe malaria.",
            "startOffset": 31400,
            "title": "Discussion"
        },
        {
            "endOffset": 29223,
            "parents": [],
            "secId": "s0080",
            "sentence": "Firstly, it is interesting that both HLA Class I and Class II allele groups were associated with RTS,S-mediated protection in the malaria challenge model.",
            "startOffset": 29069,
            "title": "Discussion"
        },
        {
            "endOffset": 21278,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "We next acknowledged the probability of linkage disequilibrium and considered whether the associations of these six allele groups were independent of each other by repeating the logistic regression analyses, adjusting for the other allele groups.",
            "startOffset": 21032,
            "title": "HLA allele groups significantly associated with RTS,S-mediated protection may not be independent"
        },
        {
            "endOffset": 24403,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Conversely, a significant association was found between HLA-B\u221753 and lower anti-CS titres (Coeff: \u22120.84; p = 0.001).",
            "startOffset": 24287,
            "title": "Not all HLA allele groups associated with protection in CHMI are also associated with anti-circumsporozoite titres on day of challenge"
        },
        {
            "endOffset": 18596,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0040",
                    "title": "Statistics"
                }
            ],
            "secId": "s0050",
            "sentence": "Primary analyses were unadjusted for other allele groups, however for allele groups where significant associations were detected with protection or immunogenicity, logistic regression models were re-run adjusting for other significant allele groups, or anti-CS titres at day of challenge.",
            "startOffset": 18308,
            "title": "Secondary analyses"
        },
        {
            "endOffset": 14413,
            "parents": [],
            "secId": "s0005",
            "sentence": "Any evidence of an association between HLA haplotype and RTS,S vaccination outcome may contribute to a better understanding of mechanisms of vaccine action, and help explain the subject response heterogeneity in vaccine trials.",
            "startOffset": 14186,
            "title": "Introduction"
        },
        {
            "endOffset": 24286,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Of the three allele groups previously linked with protection, HLA-A\u221701 (Coeff: 0.29; p = 0.047) and HLA-B\u221708 (Coeff: 0.43; p = 0.005) were associated with increased anti-CS titres on the day of challenge.",
            "startOffset": 24082,
            "title": "Not all HLA allele groups associated with protection in CHMI are also associated with anti-circumsporozoite titres on day of challenge"
        },
        {
            "endOffset": 11722,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 11541,
                    "startOffset": 11538
                },
                "b0015": {
                    "endOffset": 11612,
                    "startOffset": 11609
                },
                "b0020": {
                    "endOffset": 11721,
                    "startOffset": 11718
                }
            },
            "secId": "s0005",
            "sentence": "RTS,S/AS01 has been tested in a Phase III trial [2] and received a positive opinion from the European Medicines Agency [3], but further evaluation is ongoing and the underlying mechanisms of action are still not well understood [4].",
            "startOffset": 11490,
            "title": "Introduction"
        },
        {
            "endOffset": 17578,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0040",
                    "title": "Statistics"
                }
            ],
            "secId": "s0045",
            "sentence": "Odds ratios (ORs) of protected subjects with a specific allele group versus protected subjects without the allele group were calculated using logistic regression.",
            "startOffset": 17416,
            "title": "Primary analyses"
        },
        {
            "endOffset": 11364,
            "parents": [],
            "secId": "s0005",
            "sentence": "When simultaneously expressed in yeast cells together with free HBsAg, these antigens assemble into particulate structures.",
            "startOffset": 11241,
            "title": "Introduction"
        },
        {
            "endOffset": 29643,
            "parents": [],
            "secId": "s0080",
            "sentence": "While there is much data supporting a hypothetical role for CD8+ T cells in pre-erythrocytic immune responses, there has been no significant data from any RTS,S trials indicating a substantial CD8+ T cell contribution.",
            "startOffset": 29425,
            "title": "Discussion"
        },
        {
            "endOffset": 11895,
            "parents": [],
            "secId": "s0005",
            "sentence": "Furthermore, there is significant variation in responses of vaccinated subjects both in the field and in controlled human malaria infections (CHMI) in non-endemic settings.",
            "startOffset": 11723,
            "title": "Introduction"
        },
        {
            "endOffset": 11489,
            "parents": [],
            "secId": "s0005",
            "sentence": "The RTS,S antigen is formulated with the AS01E adjuvant system which contains the immunostimulants MPL, QS21, and liposomes.",
            "startOffset": 11365,
            "title": "Introduction"
        },
        {
            "endOffset": 29795,
            "parents": [],
            "secId": "s0080",
            "sentence": "The role of HLA Class II allele groups and CD4+ T cells is expected, through help for antibody production, though the significance remains unconfirmed.",
            "startOffset": 29644,
            "title": "Discussion"
        },
        {
            "endOffset": 29424,
            "parents": [],
            "secId": "s0080",
            "sentence": "This suggests that both CD4+ T cell (through HLA Class II peptide presentation) and CD8+ T cell (through HLA Class I peptide presentation) responses may contribute to the protective efficacy of RTS,S.",
            "startOffset": 29224,
            "title": "Discussion"
        },
        {
            "endOffset": 28928,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 28926,
                    "startOffset": 28922
                }
            },
            "secId": "s0080",
            "sentence": "Indeed, such FDR approaches are often not appropriate in genetic studies [21]).",
            "startOffset": 28849,
            "title": "Discussion"
        },
        {
            "endOffset": 31399,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 31398,
                    "startOffset": 31394
                }
            },
            "secId": "s0080",
            "sentence": "Finally, it is worth noting that the association between HLA-B\u221753 and lack of RTS,S-mediated protection does not immediately appear to be consistent with previously published data; it has been reported that HLA-B\u221753 is associated with protection against severe malaria in the field [24].",
            "startOffset": 31112,
            "title": "Discussion"
        },
        {
            "endOffset": 25884,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Supporting the data in Table 4 that showed no relationship between HLA-A\u221703 or HLA-DRB1\u221707 and anti-CS titres, controlling for anti-CS titres did not prevent our ability to detect a significant association between these allele groups and lack of protection (HLA-A\u221703, OR: 0.26; p = 0.002; HLA-DRB1\u221707, OR: 0.37, p = 0.014).",
            "startOffset": 25561,
            "title": "Associations between HLA and protection are not entirely explained by anti-circumsporozoite titres, suggesting a role for other mechanisms of HLA influence on immune responses to RTS,S"
        },
        {
            "endOffset": 15960,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "For analysis, subjects were then classified based on broad HLA class I and class II related groups (equivalent to serologically defined antigens) without further stratification by 4-digit HLA allele definition.",
            "startOffset": 15750,
            "title": "HLA typing"
        },
        {
            "endOffset": 18307,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0040",
                    "title": "Statistics"
                }
            ],
            "secId": "s0050",
            "sentence": "Supplementary to the efficacy analyses, immunogenicity analyses were also performed comparing the anti-CS titres between subjects with and without an allele group using linear regression, adjusting for trial or trial, adjuvant, and schedule.",
            "startOffset": 18066,
            "title": "Secondary analyses"
        },
        {
            "endOffset": 18043,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0040",
                    "title": "Statistics"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 18003,
                    "startOffset": 17999
                }
            },
            "secId": "s0045",
            "sentence": "We do not consider adjusting for multiplicity of testing to be strictly necessary [21], as detailed in the Section Discussion.",
            "startOffset": 17917,
            "title": "Primary analyses"
        },
        {
            "endOffset": 11057,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 11056,
                    "startOffset": 11053
                }
            },
            "secId": "s0005",
            "sentence": "Malaria caused by the Plasmodium falciparum parasite caused 438,000 deaths in 2015 and remains one of the major causes of mortality in children under five-years old in sub-Saharan Africa [1].",
            "startOffset": 10866,
            "title": "Introduction"
        },
        {
            "endOffset": 17085,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0020": {
                    "endOffset": 17084,
                    "startOffset": 17075
                },
                "b0075": {
                    "endOffset": 17084,
                    "startOffset": 17075
                },
                "b0080": {
                    "endOffset": 17084,
                    "startOffset": 17075
                },
                "b0085": {
                    "endOffset": 17084,
                    "startOffset": 17075
                },
                "b0090": {
                    "endOffset": 17084,
                    "startOffset": 17075
                }
            },
            "secId": "s0035",
            "sentence": "ELISAs for anti-CS protein (NANP repeat) IgG titres (henceforth referred to as anti-CS titres) were performed as previously described [4,15\u201318].",
            "startOffset": 16941,
            "title": "ELISAs"
        },
        {
            "endOffset": 23813,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "We therefore sought to establish whether the associations between HLA allele groups and protection in the CHMI system were linked to a relationship between the allele groups and anti-CS titres.",
            "startOffset": 23620,
            "title": "Not all HLA allele groups associated with protection in CHMI are also associated with anti-circumsporozoite titres on day of challenge"
        },
        {
            "endOffset": 13709,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 13707,
                    "startOffset": 13703
                }
            },
            "secId": "s0005",
            "sentence": "Indeed, one allele group associated with lower antibody titers to HBsAg, HLA-DRB1\u221707, was detected in a significantly higher proportion of non-protected subjects as compared to protected subjects in a small CHMI trial (n = 26, Fisher\u2019s exact test p = 0.03 [12]).",
            "startOffset": 13447,
            "title": "Introduction"
        },
        {
            "endOffset": 32040,
            "parents": [],
            "secId": "s0080",
            "sentence": "The HLA backgrounds may explain some of the observed within and between trial heterogeneity.",
            "startOffset": 31948,
            "title": "Discussion"
        },
        {
            "endOffset": 32203,
            "parents": [],
            "secId": "s0080",
            "sentence": "This work may inform further mode of action analyses and contribute to the ongoing efforts for generation of second generation highly protective malaria vaccines.",
            "startOffset": 32041,
            "title": "Discussion"
        },
        {
            "endOffset": 19331,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Three of the 40 allele groups had insufficient numbers of positive donors for analysis by logistic regression.",
            "startOffset": 19221,
            "title": "HLA allele groups are associated with protective efficacy of RTS,S vaccination"
        },
        {
            "endOffset": 23433,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The primary immunogenicity read-out for RTS,S clinical trials has historically been anti-CS antibody titres to the central amino acid repeat region, as these antibodies are thought to play the major RTS,S-mediated role in preventing sporozoite invasion of hepatocytes.",
            "startOffset": 23165,
            "title": "Not all HLA allele groups associated with protection in CHMI are also associated with anti-circumsporozoite titres on day of challenge"
        },
        {
            "endOffset": 26793,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Finally, the three allele groups that were associated with higher (HLA-A\u221701, HLA-B\u221708) or lower (HLA-B\u221753) anti-CS titres no longer had statistically significant associations with protection (HLA-A\u221701, HLA-B\u221708) or lack of protection (HLA-B\u221753) when we controlled for anti-CS titres.",
            "startOffset": 26510,
            "title": "Associations between HLA and protection are not entirely explained by anti-circumsporozoite titres, suggesting a role for other mechanisms of HLA influence on immune responses to RTS,S"
        },
        {
            "endOffset": 23619,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Specifically, in Phase II trials including CHMI, the anti-CS IgG titres on the day of malaria challenge (three weeks after the last vaccine administration) are particularly of interest.",
            "startOffset": 23434,
            "title": "Not all HLA allele groups associated with protection in CHMI are also associated with anti-circumsporozoite titres on day of challenge"
        },
        {
            "endOffset": 24081,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "To address this, the anti-CS (NANP repeat) IgG titres, available for 219 of the 222 subjects, were log transformed and compared between subjects with and without each of the six allele groups by linear regression, adjusting for trial, adjuvant, and schedule (Table 4).",
            "startOffset": 23813,
            "title": "Not all HLA allele groups associated with protection in CHMI are also associated with anti-circumsporozoite titres on day of challenge"
        },
        {
            "endOffset": 16507,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0020": {
                    "endOffset": 16506,
                    "startOffset": 16497
                },
                "b0075": {
                    "endOffset": 16506,
                    "startOffset": 16497
                },
                "b0080": {
                    "endOffset": 16506,
                    "startOffset": 16497
                },
                "b0085": {
                    "endOffset": 16506,
                    "startOffset": 16497
                },
                "b0090": {
                    "endOffset": 16506,
                    "startOffset": 16497
                },
                "b0095": {
                    "endOffset": 16506,
                    "startOffset": 16497
                }
            },
            "secId": "s0030",
            "sentence": "This protocol was been previously described and is used to generate efficacy endpoint data in the trials included here [4,15\u201319].",
            "startOffset": 16378,
            "title": "Controlled human malaria infection (CHMI) model"
        },
        {
            "endOffset": 18958,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 18843,
                    "startOffset": 18834
                },
                "b0075": {
                    "endOffset": 18843,
                    "startOffset": 18834
                },
                "b0080": {
                    "endOffset": 18843,
                    "startOffset": 18834
                },
                "b0085": {
                    "endOffset": 18843,
                    "startOffset": 18834
                },
                "b0090": {
                    "endOffset": 18843,
                    "startOffset": 18834
                },
                "b0095": {
                    "endOffset": 18843,
                    "startOffset": 18834
                }
            },
            "secId": "s0055",
            "sentence": "The prevalence of HLA-A/B/DRB1 allele groups varied across the six trials [4,15\u201319], emphasizing the importance of adjusting for trial in the analyses, as described in Section Materials and Methods.",
            "startOffset": 18760,
            "title": "Results"
        },
        {
            "endOffset": 12066,
            "parents": [],
            "secId": "s0005",
            "sentence": "It is of interest to understand what factors may contribute to this heterogeneity in order to guide further development and improvement of malaria vaccination strategies.",
            "startOffset": 11896,
            "title": "Introduction"
        },
        {
            "endOffset": 14186,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 14185,
                    "startOffset": 14178
                },
                "b0070": {
                    "endOffset": 14185,
                    "startOffset": 14178
                }
            },
            "secId": "s0005",
            "sentence": "The portion of CS protein expressed in RTS,S contains both CD4+ and CD8+ T cell epitopes [13] and CS protein is likely expressed early in the liver stage, which would allow HLA Class I presentation by hepatocytes to CD8+ T cells [13,14].",
            "startOffset": 13949,
            "title": "Introduction"
        },
        {
            "endOffset": 28848,
            "parents": [],
            "secId": "s0080",
            "sentence": "While it is important to note the possibility of false positive results among the associations detected by these initial analyses, our relatively small sample size (and thus low power for a genetic association analysis) does not lend itself to use of stringent false discovery rate (FDR) control methods.",
            "startOffset": 28544,
            "title": "Discussion"
        },
        {
            "endOffset": 18759,
            "parents": [],
            "secId": "s0055",
            "sentence": "A total of 222 RTS,S-vaccinated subjects, with 40 different broad serotype HLA-A, HLA-B, and HLA-DRB1 allele groups, were available for analysis (Table 1).",
            "startOffset": 18604,
            "title": "Results"
        },
        {
            "endOffset": 22182,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "However, if we only adjust for HLA-A\u221703, HLA-B\u221753, HLA-DRB1\u221715/\u221716 and HLA-DRB1\u221707, these associations are maintained for both allele groups (HLA-A\u221701, OR: 2.40, p = 0.027; HLA-B\u221708, OR: 2.33, p = 0.046).",
            "startOffset": 21978,
            "title": "HLA allele groups significantly associated with RTS,S-mediated protection may not be independent"
        },
        {
            "endOffset": 17916,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0040",
                    "title": "Statistics"
                }
            ],
            "secId": "s0045",
            "sentence": "Logistic regression was then used to adjust for trial, adjuvant, and schedule (differentiating between standard schedule, delayed fractional dose, and schedules with an adenovirus viral vector or adenovirus and modified vaccinia Ankara [MVA] viral vectors).",
            "startOffset": 17659,
            "title": "Primary analyses"
        },
        {
            "endOffset": 21528,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Using this approach, a statistically significant association between HLA-DRB1\u221715/\u221716 and protection was still detected, indicating that a putative protective effect mediated by this allele group is not linked to the presence of HLA-A\u221701 or HLA-B\u221708.",
            "startOffset": 21279,
            "title": "HLA allele groups significantly associated with RTS,S-mediated protection may not be independent"
        },
        {
            "endOffset": 21765,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Similarly, the associations between HLA-A\u221703, HLA-B\u221753 and HLA-DRB1\u221707 and lack of protection were maintained, suggesting that these relationships are independent of each other, and could potentially exert a cumulative effect (Table 3).",
            "startOffset": 21529,
            "title": "HLA allele groups significantly associated with RTS,S-mediated protection may not be independent"
        },
        {
            "endOffset": 20933,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "We interpret this to be a reflection of the decreased power due to the reduced sample size rather than an impact of the use of adenovirus or MVA viral vectors on the associations between HLA and protection (Supplemental Table 1), although it could be of interest to compare vaccine administration modalities in future studies.",
            "startOffset": 20607,
            "title": "HLA allele groups are associated with protective efficacy of RTS,S vaccination"
        },
        {
            "endOffset": 20606,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Similarly, if subjects who received viral vectors in addition to RTS,S were excluded from the analyses, the majority of the associations remained statistically significant at the 0.05 level, with the exception of HLA-A\u221703.",
            "startOffset": 20384,
            "title": "HLA allele groups are associated with protective efficacy of RTS,S vaccination"
        },
        {
            "endOffset": 13446,
            "parents": [],
            "secId": "s0005",
            "sentence": "As HLA Class II alleles will influence the CD4+ T cell response, HLA haplotypes could therefore potentially explain some of the heterogeneity in protective efficacy observed in CHMI.",
            "startOffset": 13264,
            "title": "Introduction"
        },
        {
            "endOffset": 30558,
            "parents": [],
            "secId": "s0080",
            "sentence": "Indeed, 25 of the study subjects from the six Phase II trials (conducted in the US and UK) included in this analysis had these three allele groups, though we cannot confirm on the same chromosome.",
            "startOffset": 30362,
            "title": "Discussion"
        },
        {
            "endOffset": 26938,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "This suggests that the mechanism linking these three allele groups and protection is related to the generation of the anti-CS antibody response.",
            "startOffset": 26794,
            "title": "Associations between HLA and protection are not entirely explained by anti-circumsporozoite titres, suggesting a role for other mechanisms of HLA influence on immune responses to RTS,S"
        },
        {
            "endOffset": 13065,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 13064,
                    "startOffset": 13056
                },
                "b0045": {
                    "endOffset": 13064,
                    "startOffset": 13056
                },
                "b0050": {
                    "endOffset": 13064,
                    "startOffset": 13056
                }
            },
            "secId": "s0005",
            "sentence": "It therefore seems likely that HLA may play a role in RTS,S responses, particularly given the strong evidence of associations between hepatitis B vaccine immunogenicity (as the RTS,S antigen includes CS protein co-expressed on the hepatitis B vaccine particle) and HLA-DR, HLA-DQ, and HLA-DP alleles (as reviewed in a 2013 meta-analysis [6,9,10].",
            "startOffset": 12719,
            "title": "Introduction"
        },
        {
            "endOffset": 28543,
            "parents": [],
            "secId": "s0080",
            "sentence": "Consequently, we acknowledge the risk of type I errors in this first set of analyses due to the multiplicity of testing; the expected false positive rate for 37 tests is 1.85 if we use the standard alpha value of 0.05 as the cut-off for determining whether a p value indicates a significant result (therefore expecting 5% of all tests to result in a Type I error, i.e. a false positive).",
            "startOffset": 28156,
            "title": "Discussion"
        },
        {
            "endOffset": 22424,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 22422,
                    "startOffset": 22418
                }
            },
            "secId": "s0065",
            "sentence": "This is consistent with the known existence of an \u2018ancestral haplotype\u2019, which is a common, highly conserved HLA haplotype, including both the HLA-A\u221701 and HLA-B\u221708 allele groups, known to have effects on immune responses (reviewed in [22]).",
            "startOffset": 22183,
            "title": "HLA allele groups significantly associated with RTS,S-mediated protection may not be independent"
        },
        {
            "endOffset": 21977,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "In contrast, the associations between HLA-A\u221701 or HLA-B\u221708 and RTS,S-mediated protection during CHMI were no longer significant when the presence or absence of other allele groups is taken into account (Table 3).",
            "startOffset": 21765,
            "title": "HLA allele groups significantly associated with RTS,S-mediated protection may not be independent"
        },
        {
            "endOffset": 16670,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Briefly, vaccinees are infected with 3D7 strain P. falciparum through the bite of five infected mosquitoes, approximately three weeks after the final vaccination.",
            "startOffset": 16508,
            "title": "Controlled human malaria infection (CHMI) model"
        },
        {
            "endOffset": 12527,
            "parents": [],
            "secId": "s0005",
            "sentence": "HLA alleles vary enormously at a population level and influence an individual\u2019s response to a pathogen or vaccine antigen as the specificity of the peptide-binding pockets of each HLA molecule restricts the peptides that can be processed and presented to T cells.",
            "startOffset": 12264,
            "title": "Introduction"
        },
        {
            "endOffset": 14723,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "All studies and analyses have been performed under due IRB authorization and oversight, with subject informed consent.",
            "startOffset": 14605,
            "title": "Ethics statement"
        },
        {
            "endOffset": 25413,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Following on from these associations between HLA allele groups with both protection/non-protection and anti-CS titres, we considered whether a relationship with anti-CS titre on day of challenge determined the relationship between allele groups and protection or lack of protection.",
            "startOffset": 25131,
            "title": "Associations between HLA and protection are not entirely explained by anti-circumsporozoite titres, suggesting a role for other mechanisms of HLA influence on immune responses to RTS,S"
        },
        {
            "endOffset": 29069,
            "parents": [],
            "secId": "s0080",
            "sentence": "Nonetheless, the results and hypotheses generated by this exploratory analysis, discussed below, require further exploration and validation.",
            "startOffset": 28929,
            "title": "Discussion"
        },
        {
            "endOffset": 22725,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 22610,
                    "startOffset": 22606
                }
            },
            "secId": "s0065",
            "sentence": "Indeed, 14.9% of trial participants were positive for both HLA-A\u221701 and HLA-B\u221708, consistent with these allele groups being part of the most common haplotype in Caucasian Americans [23], though we cannot be certain the allele groups were on the same chromosome for all subjects and thus co-inherited.",
            "startOffset": 22425,
            "title": "HLA allele groups significantly associated with RTS,S-mediated protection may not be independent"
        },
        {
            "endOffset": 13948,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 13820,
                    "startOffset": 13816
                }
            },
            "secId": "s0005",
            "sentence": "Additionally, although RTS,S clinical trial data have not demonstrated CD8+ T cell activation (reviewed in [11]), it is possible that evaluations of cellular immunity using peripheral blood are not representative of responses in the liver.",
            "startOffset": 13709,
            "title": "Introduction"
        },
        {
            "endOffset": 27206,
            "parents": [],
            "secId": "s0080",
            "sentence": "A total of 222 subjects from six different RTS,S Phase II trials with CHMI were included in these analyses, ten different HLA-A allele groups, 20 HLA-B allele groups (both HLA Class I), and ten HLA-DRB1 allele groups (HLA Class II) included in the analyses.",
            "startOffset": 26949,
            "title": "Discussion"
        },
        {
            "endOffset": 30699,
            "parents": [],
            "secId": "s0080",
            "sentence": "On the other hand, HLA-B\u221753, which is here associated with lack of protection, is known to be at a higher frequency in sub-Saharan Africans.",
            "startOffset": 30559,
            "title": "Discussion"
        },
        {
            "endOffset": 26510,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "However, this reflects a relatively small change in Odds Ratio (OR = 1.90 in analysis without adjustment for anti-CS titres versus OR = 1.85 when adjusted for anti-CS titres) and, given the relatively small size of this exploratory analysis we avoid over-interpretation of this difference.",
            "startOffset": 26221,
            "title": "Associations between HLA and protection are not entirely explained by anti-circumsporozoite titres, suggesting a role for other mechanisms of HLA influence on immune responses to RTS,S"
        },
        {
            "endOffset": 29977,
            "parents": [],
            "secId": "s0080",
            "sentence": "It is also possible that associations between these HLA allele groups and protection are mediated by other genes co-inherited with these allele groups due to linkage disequilibrium.",
            "startOffset": 29796,
            "title": "Discussion"
        },
        {
            "endOffset": 12263,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 12261,
                    "startOffset": 12258
                }
            },
            "secId": "s0005",
            "sentence": "While there are many parameters that may contribute to vaccine responses, it is well-established that an individual subject\u2019s genetics, such as HLA haplotype, can play a key role (reviewed in [5]).",
            "startOffset": 12066,
            "title": "Introduction"
        },
        {
            "endOffset": 25560,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "To achieve this, we repeated the logistic regression analyses, adjusting for anti-CS titre in addition to trial, adjuvant, and schedule (Table 5).",
            "startOffset": 25414,
            "title": "Associations between HLA and protection are not entirely explained by anti-circumsporozoite titres, suggesting a role for other mechanisms of HLA influence on immune responses to RTS,S"
        },
        {
            "endOffset": 28155,
            "parents": [],
            "secId": "s0080",
            "sentence": "Primary analyses were performed for 37 allele groups as if a cut-off threshold was set for a minimum number of positive subjects to include in the analyses, we would be unable to detect any strong associations with less prevalent allele groups.",
            "startOffset": 27911,
            "title": "Discussion"
        },
        {
            "endOffset": 12718,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 12717,
                    "startOffset": 12712
                },
                "b0030": {
                    "endOffset": 12717,
                    "startOffset": 12712
                },
                "b0035": {
                    "endOffset": 12717,
                    "startOffset": 12712
                },
                "b0040": {
                    "endOffset": 12717,
                    "startOffset": 12712
                }
            },
            "secId": "s0005",
            "sentence": "Associations between HLA background and immunogenicity have been demonstrated for a range of vaccines, including hepatitis B, influenza, anthrax, measles, rubella, and meningococcal C [5\u20138].",
            "startOffset": 12528,
            "title": "Introduction"
        },
        {
            "endOffset": 26220,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "In contrast, while no relationship was found between HLA-DRB1\u221715/\u221716 and anti-CS titres at the day of challenge (Table 4), adjusting for anti-CS titre did increase the p value (p = 0.077, Table 5) as compared to the original analysis (p = 0.041, Table 2) so that the association was no longer significant at the 0.05 significance level.",
            "startOffset": 25884,
            "title": "Associations between HLA and protection are not entirely explained by anti-circumsporozoite titres, suggesting a role for other mechanisms of HLA influence on immune responses to RTS,S"
        },
        {
            "endOffset": 31112,
            "parents": [],
            "secId": "s0080",
            "sentence": "The results presented here therefore suggest differences in HLA background may contribute to within-trial and between trial heterogeneities.",
            "startOffset": 30972,
            "title": "Discussion"
        },
        {
            "endOffset": 20105,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The results were very similar when analyses were adjusted for trial only, or for trial, adjuvant and schedule (Supplemental Table 1).",
            "startOffset": 19972,
            "title": "HLA allele groups are associated with protective efficacy of RTS,S vaccination"
        },
        {
            "endOffset": 27516,
            "parents": [],
            "secId": "s0080",
            "sentence": "We have demonstrated statistically significant associations between multiple HLA Class I and Class II allele groups and protection in the Phase II malaria challenge model: HLA-A\u221701 and HLA-B\u221708 were associated with protection whereas HLA-A\u221703, HLA-B\u221753 and HLA-DRB1\u221707 were associated with lack of protection.",
            "startOffset": 27207,
            "title": "Discussion"
        },
        {
            "endOffset": 24944,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "While we have accounted for this by adjusting for trial in the statistical analyses, it does mean that the coefficients should not be interpreted as relating to changes in magnitude in anti-CS responses in any particular assay.",
            "startOffset": 24717,
            "title": "Not all HLA allele groups associated with protection in CHMI are also associated with anti-circumsporozoite titres on day of challenge"
        },
        {
            "endOffset": 32421,
            "parents": [],
            "secId": "s0085",
            "sentence": "The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.",
            "startOffset": 32213,
            "title": "Disclaimer"
        },
        {
            "endOffset": 14948,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Two hundred and twenty-two subjects vaccinated with RTS,S in six different CHMI clinical trials, and treated as per protocol, were available for inclusion in this analysis, as summarized in Table 1.",
            "startOffset": 14750,
            "title": "Clinical trials included"
        },
        {
            "endOffset": 17395,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "All statistical analyses were performed in STATA.",
            "startOffset": 17346,
            "title": "Statistics"
        },
        {
            "endOffset": 24716,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "While these relatively low coefficients could suggest a limited relationship between HLA allele groups and anti-CS titres generated by RTS,S vaccination, it is important to recognise that the range of anti-CS titres reported in each of the trials is heavily influenced by the assay used to measure the IgG titres.",
            "startOffset": 24403,
            "title": "Not all HLA allele groups associated with protection in CHMI are also associated with anti-circumsporozoite titres on day of challenge"
        },
        {
            "endOffset": 27723,
            "parents": [],
            "secId": "s0080",
            "sentence": "These results indicate a role for HLA haplotype in determining subject responses and protective efficacy of RTS,S vaccination.",
            "startOffset": 27597,
            "title": "Discussion"
        },
        {
            "endOffset": 20383,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Although individual trials do contain multiple adjuvant and schedule regimes (Table 1), this indicates that any variation in the relationship between HLA and RTS,S-mediated protection driven by adjuvant or schedule was likely adequately captured by controlling for trial alone.",
            "startOffset": 20106,
            "title": "HLA allele groups are associated with protective efficacy of RTS,S vaccination"
        },
        {
            "endOffset": 16130,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "To note, the HLA-DRB1\u221702 serotype consists of the HLA-DRB1\u221715/\u221716 allele groups, and thus for clarity we have used the designation HLA-DRB1\u221715/\u221716 throughout this paper.",
            "startOffset": 15961,
            "title": "HLA typing"
        },
        {
            "endOffset": 11240,
            "parents": [],
            "secId": "s0005",
            "sentence": "RTS,S is a candidate malaria vaccine antigen including a carboxy-terminal segment of the P. falciparum circumsporozoite (CS) protein fused to the hepatitis B surface antigen (HBsAg).",
            "startOffset": 11058,
            "title": "Introduction"
        },
        {
            "endOffset": 14564,
            "parents": [],
            "secId": "s0005",
            "sentence": "The availability of pooled data from various Phase II trials permits a higher-powered analysis of HLA associations with protection and immunogenicity.",
            "startOffset": 14414,
            "title": "Introduction"
        },
        {
            "endOffset": 16827,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Parasitemia is then monitored daily, using blood smears, between five and 18 days post-challenge, and then every alternate day until 28 days post-challenge.",
            "startOffset": 16671,
            "title": "Controlled human malaria infection (CHMI) model"
        },
        {
            "endOffset": 23028,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "For the purposes of this analysis, this means that it is not possible to differentiate between the putative effects associated with HLA-A\u221701 and HLA-B\u221708, but does therefore raise intriguing suggestions regarding the impact of common haplotypes on RTS,S vaccine efficacy, as detailed in the Discussion.",
            "startOffset": 22726,
            "title": "HLA allele groups significantly associated with RTS,S-mediated protection may not be independent"
        },
        {
            "endOffset": 30971,
            "parents": [],
            "secId": "s0080",
            "sentence": "If these HLA allele groups do influence RTS,S-mediated protection, we would potentially expect to see lower vaccine immunogenicity and efficacy in populations with a lower prevalence of \u2018protective\u2019 allele groups and a higher prevalence of \u2018non-protective\u2019 allele groups.",
            "startOffset": 30700,
            "title": "Discussion"
        },
        {
            "endOffset": 15749,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "HLA typing was performed on whole blood or buccal samples using standardized high resolution molecular typing (PCR) at the Georgetown University C. W Bill Young Marrow Donor Service and Testing Center, Washington DC; the Transplant Immunology Laboratory at the Walter Reed National Military Medical Center, Bethesda, MD, or the University of Oxford, Oxford, UK.",
            "startOffset": 15388,
            "title": "HLA typing"
        },
        {
            "endOffset": 17345,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Trial participants were coded 0/1 for each of the 40 alleles groups detected, and also assigned codes for adjuvant received, vaccination schedule, whether they received a viral vector in addition to RTS,S, and the trial in which they participated.",
            "startOffset": 17098,
            "title": "Statistics"
        },
        {
            "endOffset": 30361,
            "parents": [],
            "refoffsets": {
                "b0110": {
                    "endOffset": 30359,
                    "startOffset": 30355
                },
                "b0115": {
                    "endOffset": 30292,
                    "startOffset": 30288
                }
            },
            "secId": "s0080",
            "sentence": "Secondly, it is intriguing that several of the allele groups associated with protection are known to be of lower frequency in sub-Saharan African populations, specifically HLA-A\u221701 and HLA-B\u221708 which are both part of the highly conserved A1B8DR3 \u2018ancestral haplotype\u2019 which is particularly common in Caucasians [23] and is known to have effects on immune responses (reviewed in [22]).",
            "startOffset": 29977,
            "title": "Discussion"
        },
        {
            "endOffset": 15240,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0020": {
                    "endOffset": 15193,
                    "startOffset": 15190
                },
                "b0075": {
                    "endOffset": 15108,
                    "startOffset": 15104
                },
                "b0080": {
                    "endOffset": 15124,
                    "startOffset": 15120
                },
                "b0085": {
                    "endOffset": 15138,
                    "startOffset": 15134
                },
                "b0090": {
                    "endOffset": 15166,
                    "startOffset": 15162
                },
                "b0095": {
                    "endOffset": 15225,
                    "startOffset": 15221
                }
            },
            "secId": "s0020",
            "sentence": "Further details on the trials can be found using the clinicaltrials.gov identifier numbers and/or in the published reports of the main findings: WRMAL-003 [15], WRMAL-012 [16], MAL027 ([17]; NCT00075049), MAL068 ([18]; NCT01366534), MAL071 ([4]; NCT01857869), and VAC055 ([19]; NCT01883609).",
            "startOffset": 14949,
            "title": "Clinical trials included"
        },
        {
            "endOffset": 17658,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0040",
                    "title": "Statistics"
                }
            ],
            "secId": "s0045",
            "sentence": "Kaplan-Meier curves were also produced to illustrate these unadjusted analyses.",
            "startOffset": 17579,
            "title": "Primary analyses"
        },
        {
            "endOffset": 16932,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "To note, unvaccinated subjects - who all became infected during CHMI - are not included in the analyses.",
            "startOffset": 16828,
            "title": "Controlled human malaria infection (CHMI) model"
        },
        {
            "endOffset": 15375,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The main differences between these trials relate to the vaccination schedule and adjuvant used in the RTS,S formulation (see Table 1).",
            "startOffset": 15241,
            "title": "Clinical trials included"
        },
        {
            "endOffset": 16377,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 16335,
                    "startOffset": 16331
                }
            },
            "secId": "s0030",
            "sentence": "Subjects included in these analyses underwent mosquito-delivered controlled human malaria infection (CHMI) according to comparable standard procedures [20] following vaccination to assess efficacy.",
            "startOffset": 16180,
            "title": "Controlled human malaria infection (CHMI) model"
        },
        {
            "endOffset": 13263,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 13261,
                    "startOffset": 13257
                }
            },
            "secId": "s0005",
            "sentence": "While the protection mediated by RTS,S is thought to be primarily dependent on antibodies, CD4+ T cell responses have also been shown to correlate with protection in some studies (reviewed in [11]).",
            "startOffset": 13065,
            "title": "Introduction"
        },
        {
            "endOffset": 19793,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Three allele groups were associated with protection, HLA-A\u221701 (OR: 2.36, p = 0.019), HLA-B\u221708 (OR: 2.51, p = 0.020), and HLA-DRB1\u221715/\u221716 (OR: 1.90, p = 0.041), and three allele groups were associated with lack of protection HLA-A\u221703 (OR: 0.44, p = 0.026), HLA-B\u221753 (OR: 0.16, p = 0.011), and HLA-DRB1\u221707 (OR: 0.36, p = 0.005).",
            "startOffset": 19467,
            "title": "HLA allele groups are associated with protective efficacy of RTS,S vaccination"
        },
        {
            "endOffset": 19972,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Interestingly, there was no strong evidence that protective HLA-A\u221701, HLA-B\u221708, and HLA-DRB1\u221715/\u221716 allele groups were associated with substantial delays to parasitemia (Fig. 1).",
            "startOffset": 19794,
            "title": "HLA allele groups are associated with protective efficacy of RTS,S vaccination"
        },
        {
            "endOffset": 31947,
            "parents": [],
            "secId": "s0080",
            "sentence": "To conclude, the data presented here suggest a role for HLA genotype in RTS,S-mediated protection from malaria which is consistent with a role for both CD4+ and CD8+ T cells in protective immunity.",
            "startOffset": 31750,
            "title": "Discussion"
        },
        {
            "endOffset": 19220,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The proportion of subjects protected was compared between subjects positive and negative for each allele group using logistic regression, adjusting for trial, adjuvant and schedule.",
            "startOffset": 19039,
            "title": "HLA allele groups are associated with protective efficacy of RTS,S vaccination"
        }
    ],
    "docId": "S0264410X18301427",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "carolyn.nielsen@ndm.ox.ac.uk",
                "first": "C. M.",
                "initial": "C.M.",
                "last": "Nielsen"
            },
            {
                "email": null,
                "first": "J.",
                "initial": "J.",
                "last": "Vekemans"
            },
            {
                "email": null,
                "first": "M.",
                "initial": "M.",
                "last": "Lievens"
            },
            {
                "email": null,
                "first": "K. E.",
                "initial": "K.E.",
                "last": "Kester"
            },
            {
                "email": null,
                "first": "J. A.",
                "initial": "J.A.",
                "last": "Regules"
            },
            {
                "email": "cockenhouse@path.org",
                "first": "C. F.",
                "initial": "C.F.",
                "last": "Ockenhouse"
            }
        ],
        "doi": "10.1016/j.vaccine.2018.01.069",
        "firstpage": "1637",
        "issn": "0264410X",
        "keywords": [
            "Antibody",
            "HLA",
            "Malaria",
            "Protection",
            "RTS,S"
        ],
        "lastpage": "1642",
        "openaccess": "Full",
        "pub_year": 2018,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype"
    }
}